Valbiotis SA (EPA:ALVAL)
France · Delayed Price · Currency is EUR 0.8200
-0.0100 (-1.20%)
Nov 20, 2025, 5:35 PM CET
Valbiotis Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 0.47 | 0.18 | 4.73 | 0.79 | 0.3 | 3.09 | Upgrade |
Other Revenue | 0 | 0 | - | - | - | - | Upgrade |
| 0.47 | 0.18 | 4.73 | 0.79 | 0.3 | 3.09 | Upgrade | |
Revenue Growth (YoY) | -10.06% | -96.28% | 502.93% | 163.42% | -90.36% | 3297.80% | Upgrade |
Cost of Revenue | 2.35 | 2.34 | 2.04 | - | - | - | Upgrade |
Gross Profit | -1.87 | -2.16 | 2.69 | 0.79 | 0.3 | 3.09 | Upgrade |
Selling, General & Admin | 7.7 | 7.46 | 4.18 | 3.35 | 2.62 | 2.4 | Upgrade |
Research & Development | 1.87 | 4.64 | 7.15 | 9.1 | 7.03 | 5.4 | Upgrade |
Other Operating Expenses | -3.89 | -4.47 | -2.08 | -2.03 | -2.4 | -1.98 | Upgrade |
Operating Expenses | 6 | 8.26 | 9.85 | 12.77 | 8.7 | 6.5 | Upgrade |
Operating Income | -7.87 | -10.43 | -7.16 | -11.99 | -8.41 | -3.41 | Upgrade |
Interest Expense | -0.2 | -0.23 | -0.19 | -0.23 | -0.23 | -0.42 | Upgrade |
Other Non Operating Income (Expenses) | 0.5 | 0.66 | - | -0.06 | 0.02 | -0 | Upgrade |
EBT Excluding Unusual Items | -7.57 | -9.99 | -7.35 | -12.27 | -8.61 | -3.83 | Upgrade |
Other Unusual Items | -3.51 | 0 | -0.02 | -0.04 | -0.07 | - | Upgrade |
Pretax Income | -11.08 | -9.99 | -7.37 | -12.31 | -8.68 | -3.83 | Upgrade |
Income Tax Expense | 0.04 | 0.03 | - | -0 | - | - | Upgrade |
Net Income | -11.12 | -10.03 | -7.37 | -12.31 | -8.68 | -3.83 | Upgrade |
Net Income to Common | -11.12 | -10.03 | -7.37 | -12.31 | -8.68 | -3.83 | Upgrade |
Shares Outstanding (Basic) | 16 | 16 | 12 | 10 | 9 | 7 | Upgrade |
Shares Outstanding (Diluted) | 16 | 16 | 12 | 10 | 9 | 7 | Upgrade |
Shares Change (YoY) | 11.98% | 26.74% | 23.21% | 10.45% | 22.88% | 58.63% | Upgrade |
EPS (Basic) | -0.70 | -0.63 | -0.59 | -1.22 | -0.95 | -0.51 | Upgrade |
EPS (Diluted) | -0.70 | -0.63 | -0.59 | -1.22 | -0.95 | -0.51 | Upgrade |
Free Cash Flow | -9.84 | -11.68 | -8.08 | -9.3 | -7.46 | 2.53 | Upgrade |
Free Cash Flow Per Share | -0.62 | -0.74 | -0.65 | -0.92 | -0.81 | 0.34 | Upgrade |
Gross Margin | - | - | 56.81% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | -1659.92% | -5923.86% | -151.28% | -1526.88% | -2820.80% | -110.19% | Upgrade |
Profit Margin | -2344.94% | -5696.02% | -155.67% | -1568.41% | -2913.09% | -123.84% | Upgrade |
Free Cash Flow Margin | -2076.58% | -6638.64% | -170.78% | -1185.10% | -2504.03% | 81.86% | Upgrade |
EBITDA | -8.55 | -10.31 | -6.42 | -11.13 | -7.47 | -2.37 | Upgrade |
EBITDA Margin | - | - | -135.73% | - | - | -76.65% | Upgrade |
D&A For EBITDA | -0.68 | 0.11 | 0.74 | 0.85 | 0.94 | 1.04 | Upgrade |
EBIT | -7.87 | -10.43 | -7.16 | -11.99 | -8.41 | -3.41 | Upgrade |
EBIT Margin | - | - | -151.28% | - | - | -110.19% | Upgrade |
Revenue as Reported | 0.85 | 4.64 | 6.81 | 2.81 | 2.69 | 5.1 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.